NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » pressreleases » The Safelia autoinjector developed by Nemera wins the ‘Exhibitor innovation’ award at Pharmapack

Patient focused drug delivery devices


The Safelia autoinjector developed by Nemera wins the ‘Exhibitor innovation’ award at Pharmapack

On 1 February, during the Award ceremony at Pharmapack, Safelia®, Nemera’s innovative autoinjector, was celebrated as a best in class innovation displayed at the show.

Safelia is an innovative autoinjector for prefilled syringes, available for 1ml and 2.25m sizes, suitable for large volume and high viscosity delivery through thinner needles.

Safelia can mechanically "tune" the injection thanks to design adjustments. It has been designed to ease patients’ self-injection experience and to deliver the most challenging drugs, in subcutaneous or intramuscular layers.

Key benefits of Safelia

  • Patient friendly
  • No initial injection peak
  • Constant delivery flow
  • Adjustable needle insertion speed
  • Needle insertion disconnected from injection
  • Automatic needle retraction
  • Possibility to have thinner needles.

Syringe friendly

  • Syringe is held encapsulated through the barrel
  • Syringe front housing
  • No stress on the syringe flange
  • Possibility to inject very viscous drugs.

Safelia will also be shown at:

  • DDP, 7-9 February, Palm Beach Gardens, FL, US
  • INTERPHEX, 8-10 March, New York, NY, US
  • SMI PFS East Coast, 26-27 April, Boston, MA, US
  • FCE Pharma, 23-25 May, Sao Paulo, Brazil
  • SMI PFS West Coast, 6-7 June, San Diego, CA, US
  • CPhI China, 20-22 June, Shanghai, China
  • CPhI WorldWide, 24-26 October, Frankfurt, Germany
  • PDA Prefilled syringes and Injection devices, 7-8 November, Vienna, Austria
  • CPhI India, 28-30 November, Bombay, India.

A Pharmapack Exhibitor Award recognizes the product excellence in each criterion (role for health improvement, economical interest, user consideration and quality of pitch), a competitive differentiator, and clearly reflects excellence in pharma and
biopharma development and manufacturing.

Find Nemera on the web at www.nemera.net.

Contact Patient focused drug delivery devices

Patient focused drug delivery devices